← Leaderboards
Misol Ahn
University Of California, San Francisco
$446,135
Attributed
$446,135
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $89.2K · FY2011–15$100K$75K$50K$25K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$446,135 · 1
By mechanism
K01$446,135 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Stephen J. Dearmond$6,907,203
- Bruce L Miller$34,542,477
- Serggio Carlo Lanata$3,454,493
- John W Park$1,394,711
- Arnold Kriegstein$44,761,461
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposAmyloidAmyloid Beta-Protein PrecursorAnimalsAwardAxonBaseBeta-Site App Cleaving Enzyme 1BiologyBrainBrain RegionCaliforniaCareerCell Culture TechniquesCell PhysiologyCell SurvivalCessation Of LifeCombined Modality TherapyComplexConvectionDendritesDoctor Of PhilosophyDrug CombinationsAffect
Grant awards (5)
Molecular Mechanisms of Prion Disease with Translation to Novel Therapeutics$89,227
K01 · FY2015 · AG · contact PI
Molecular Mechanisms of Prion Disease with Translation to Novel Therapeutics$89,227
K01 · FY2014 · AG · contact PI
Molecular Mechanisms of Prion Disease with Translation to Novel Therapeutics$89,227
K01 · FY2013 · AG · contact PI
Molecular Mechanisms of Prion Disease with Translation to Novel Therapeutics$89,227
K01 · FY2012 · AG · contact PI
Molecular Mechanisms of Prion Disease with Translation to Novel Therapeutics$89,227
K01 · FY2011 · AG · contact PI